Completed PHASE1 INTERVENTIONAL 1-arm NCT00744692

Reduced Intensity Conditioning for Umbilical Cord Blood Transplant in Pediatric Patients With Non-Malignant Disorders

A Pilot Study of Reduced Intensity Conditioning in Pediatric Patients <21 Years of Age With Non-Malignant Disorders Undergoing Umbilical Cord Blood Transplantation

Sponsor: Duke University

Conditions Congenital Marrow Failures Hemoglobinopathies Immunodeficiencies Inborn Errors of Metabolism Lysosomal Storage Disease Non Malignant Disorders Sickle Cell Thalassemia

Interventions Reduced Intensity Conditioning Unrelated Umbilical Cord Blood Transplant

Updated 8 times since 2017 Last updated: Jul 23, 2014 Started: Oct 31, 2008 Primary completion: Dec 31, 2012 Completion: Apr 30, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00744692, this PHASE1 trial focuses on Congenital Marrow Failures and Hemoglobinopathies and remains completed. Sponsored by Duke University, it has been updated 8 times since 2008, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2023 — Jul 2024 [monthly]

Completed PHASE1
Dec 2022 — Jan 2023 [monthly]

Completed PHASE1
Jan 2021 — Dec 2022 [monthly]

Completed PHASE1

▶ Show 3 earlier versions

Jun 2018 — Jan 2021 [monthly]

Completed PHASE1
Feb 2017 — Jun 2018 [monthly]

Completed PHASE1
Jan 2017 — Feb 2017 [monthly]

Completed PHASE1

First recorded

Oct 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Duke University

Data source: Duke University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Durham, United States